HFS
CSTL icon

Hughes Financial Services’s Castle Biosciences CSTL Stock Holding History

Hughes Financial Services’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Buy
446
+10
+2% +$328 ﹤0.01% 314
2025
Q4 		$17K Buy
436
+1
+0.2% +$32 ﹤0.01% 242
2025
Q3 		$15.1K Hold
435
– – ﹤0.01% 252
2025
Q2 		$8.6K Hold
435
– – ﹤0.01% 329
2025
Q1 		$8.6K Buy
+435
New +$10.8K ﹤0.01% 340

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hughes Financial Services's CSTL Position: Q1 2026 in Review

Hughes Financial Services increased its Castle Biosciences (CSTL) stake by 2.3% in Q1 2026, buying an estimated $328 and bringing the position to 446 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Hughes Financial Services first reported a position in CSTL in Q1 2025 and has held it in 5 quarters since. The position peaked at $17K in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Hughes Financial Services held 446 shares of Castle Biosciences worth $10.9K as of Q1 2026.
  • Hughes Financial Services bought 10 Castle Biosciences shares in Q1 2026, an estimated $328.
  • Castle Biosciences made up ﹤0.01% of Hughes Financial Services's portfolio in Q1 2026, its #314 holding.
  • Hughes Financial Services first reported a position in Castle Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Hughes Financial Services's Castle Biosciences position peaked at $17K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Hughes Financial Services's 13F filing for Q1 2026, filed 29 Apr 2026.